Lactobacillus paracasei subsp. paracasei B21060 suppresses human T-cell proliferation

Infection and Immunity

Volumn 75, Issue 4, 2007, Pages 1730-1737

  Peluso, Ilaria ^a   Fina, Daniele ^a   Caruso, Roberta ^a   Stolfi, Carmine ^a   Caprioli, Flavio ^a   Fantini, Massimo Claudio ^a   Caspani, Giorgio ^b   Grossi, Enzo ^b   Di Iorio, Laura ^a   Paone, Francesco Maria ^a   Pallone, Francesco ^a   Monteleone, Giovanni ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b Bracco SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CD28 ANTIGEN; CD3 ANTIBODY; CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; TRANSCRIPTION FACTOR FOXP3;

ARTICLE; CELL DEATH; CELL GROWTH; CELL ISOLATION; CELL PH; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; LACTOBACILLUS PARACASEI; MOLECULAR MECHANICS; MONONUCLEAR CELL; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; STRAIN DIFFERENCE; T LYMPHOCYTE ACTIVATION;

APOPTOSIS; BLOOD; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; HYDROGEN-ION CONCENTRATION; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; LACTOBACILLUS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MONOCARBOXYLIC ACID TRANSPORTERS; PEYER'S PATCHES; PROBIOTICS; SYMPORTERS;

EID: 34147162893     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01172-06     Document Type: Article

References (39)

1. Bibiloni, R., R. N. Fedorak, G. W. Tannock, K. L. Madsen, P. Gionchetti, M. Campieri, C. De Simone, and R. B. Sartor. 2005. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am. J. Gastroenterol. 100:1539-1546.
2. Borruel, N., M. Carol, F.Casellas, M. Antolin, F. de Lara, E. Espin, J. Naval, F. Guarner, and J. R. Malagelada. 2002. Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria. Gut 51:659-664.
3. Caramalho, I., T. Lopes-Carvalho, D. Ostler, S. Zelenay, M. Haury, and J. Demengeot. 2003. Regulatory T cells selectively express Toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 197:403-411.
4. + T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease. J. Exp. Med. 187:855-864.
5. + T regulatory cells. J. Immunol. 175:8051-8059.
6. Daberkow, R. L., B. R. White, R. A. Cederberg, J. B. Griffin, and J. Zempleni. 2003. Monocarboxylate transporter 1 mediates biotin uptake in human peripheral blood mononuclear cells. J. Nutr. 133:2703-2706.
7. Di Giacinto, C., M. Marinaro, M. Sanchez, W. Strober, and M. Boirivant. 2005. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10- and IL-10-dependent TGF-beta-bearing regulatory cells. J. Immunol. 174:3237-3246.
8. Duchmann, R., I. Kaiser, E. Hermann, W. Mayet, K. Ewe, and K. H. Meyer zum Buschenfelde. 1995 Tolerance exists toward resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin. Exp. Immunol. 102:448-455.
9. - T cells through Foxp3 induction and downregulation of Smad7. J. Immunol. 172:5149-5153.
10. Gionchetti, P., F. Rizzello, A. Venturi, P. Brigidi, D. Matteuzzi, G. Bazzocchi, G. Poggioli, M. Miglioli, and M. Campieri. 2000. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119:305-309.
11. Gionchetti, P., F. Rizzello, U. Helwig, A. Venturi, K. M. Lammers, P. Brigidi, B. Vitali, G. Poggioli, M. Miglioli, and M. Campieri. 2003. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 124:1202-1209.
12. Grabig, A., D. Paclik, C. Guzy, A. Dankof, D. C. Baumgart, J. Erckenbrecht, B. Raupach, U. Sonnenborn, J. Eckert, R. R. Schumann, B. Wiedenmann, A. U. Dignass, and A. Sturm. 2006. Escherichia coli strain Nissle 1917 ameliorates experimental colitis via Toll-like receptor 2- and Toll-like receptor 4-dependent pathways. Infect. Immun. 74:4075-4082.
13. Gregori, G., S. Citterio, A. Ghiani, M. Labra, S. Sgorbati, S. Brown, and M. Denis. 2001. Resolution of viable and membrane-compromised bacteria in freshwater and marine waters based on analytical flow cytometry and nucleic acid double staining. Appl. Environ. Microbiol. 67:4662-4670.
14. Heilig, H. G., E. G. Zoetendal, E. E. Vaughan, P. Marteau, A. D. Akkermans, and W. M. de Vos. 2002. Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined by specific amplification of 16S ribosomal DNA. Appl. Environ. Microbiol. 68:114-123.
15. Hessle, C., L. A. Hanson, and A. E. Wold. 1999. Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL-12 production. Clin. Exp. Immunol. 116:276-282.
16. Iwasaki, A., and R. Medzhitov. 2004. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5:987-995.
17. Komai-Koma, M., L. Jones, G. S. Ogg, D. Xu, and F. Y. Liew. 2004. TLR2 is expressed on activated T cells as a costimulatory receptor. Proc. Natl. Acad. Sci. USA 101:3029-3034.
18. Maassen, C. B., C. van Holten-Neelen, F. Balk, M. J. den Bak-Glashouwer, R. J. Leer, J. D. Laman, W. J. Boersma, and E. Claassen. 2000. Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. Vaccine 18:2613-2623.
19. Macdonald, T. T., and G. Monteleone. 2005. Immunity, inflammation, and allergy in the gut. Science 307:1920-1925.
20. Mansson, A., M. Adner, and L. O. Cardell. 2006. Toll-like receptors in cellular subsets of human tonsil T cells: altered expression during recurrent tonsillitis. Respir. Res. 7:36.
21. Miettinen, M., J. Vuopio-Varkila, and K. Varkila. 1996. Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect. Immun. 64:5403-5405.
22. Monteleone, G., J. Holloway, V. M. Salvati, S. L. Pender, P. D. Fairclough, N. Croft, and T. T. MacDonald. 2003. Activated STAT4 and a functional role for IL-12 in human Peyer's patches. J. Immunol. 170:300-307.
23. Morelli, L., D. Zonenschain, M. L. Callegari, E. Grossi, F. Malsano, and M. Fusillo. 2003. Assessment of a new synbiotic preparation in healthy volunteers: survival, persistence of probiotic strains and its effect on the indigenous flora. Nutr. J. 2:11.
24. Murray, C. M., R. Hutchinson, J. R. Bantick, G. P. Belfield, A. D. Benjamin, D. Brazma, R. V. Bundick, I. D. Cook, R. I. Craggs, S. Edwards, L. R. Evans, R. Harrison, E. Holness, A. P. Jackson, C. G. Jackson, L. P. Kingston, M. W. Perry, A. R. Ross, P. A. Rugman, S. S. Sidhu, M. Sullivan, D. A. Taylor-Fishwick, P. C. Walker, Y. M. Whitehead, D. J. Wilkinson, A. Wright, and D. K. Donald. 2005. Monocarboxylate transporter MCT1 is a target for immunosuppression. Nat. Chem. Biol. 1:371-376.
25. Nagata, S., C. McKenzie, S. L. Pender, M. Bajaj-Elliott, P. D. Fairclough, J. A. Walker-Smith, G. Monteleone, and T. T. MacDonald. 2000. Human Peyer's patch T cells are sensitized to dietary antigen and display a Th cell type 1 cytokine profile. J. Immunol. 165:5315-5321.
26. Nilsson, C., K. Kagedal, U. Johansson, and K. Ollinger. 2003. Analysis of cytosolic and lysosomal pH in apoptotic cells by flow cytometry. Methods Cell Sci. 25:185-194.
27. Pasare, C., and R. Medzhitov. 2005. Toll-like receptors: linking innate and adaptive immunity. Adv. Exp. Med. Biol. 560:11-18.
28. Pickard, K. M., A. R. Bremner, J. N. Gordon, and T. T. MacDonald. 2004. Microbial-gut interactions in health and disease. Immune responses. Best. Pract. Res. Clin. Gastroenterol. 18:271-285.
29. Rachmilewitz, D., K. Katakura, F. Karmeli, T. Hayashi, C. Reinus, B. Rudensky, S. Akira, K. Takeda, J. Lee, K. Takabayashi, and E. Raz. 2004. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 126:520-528.
30. Rousseaux, C., X. Thuru, A. Gelot, N. Barnich, C. Neut, L. Dubuquoy, C. Dubuquoy, E. Merour, K. Geboes, M. Chamaillard, A. Ouwehand, G. Leyer, D. Carcano, J. F. Colombel, D. Ardid, and P. Desreumaux. 2007. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat. Med. 15:35-37.
31. Rutgeerts, P., K. Goboes, M. Peeters, M. Hiele, F. Penninckx, R. Aerts, R. Kerremans, and G. Vantrappen. 1991. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 338:771-774.
32. Sartor, R. B. 2004. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 126:1620-1633.
33. 2+ signaling, intracellular pH, and cell volume in cell proliferation. J. Membr. Biol. 205:129-137.
34. Shanahan, F. 2000. Probiotics and inflammatory bowel disease: is there a scientific rationale? Inflamm. Bowel. Dis. 6:107-115.
35. Strober, W., I. J. Fuss, and R. S. Blumberg. 2002. The immunology of mucosal models of inflammation. Annu. Rev. Immunol. 20:495-549.
36. Sturm, A., K. Rilling, D. C. Baumgart, K. Gargas, T. Abou-Ghazale, B. Raupach, J. Eckert, R. R. Schumann, C. Enders, U. Sonnenborn, B. Wiedenmann, and A. U. Dignass. 2005. Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via Toll-like receptor 2 signaling. Infect. Immun. 73:1452-1465.
37. Sutmuller, R. P., M. H. den Brok, M. Kramer, E. J. Bennink, L. W. Toonen, B. J. Kullberg, L. A. Joosten, S. Akira, M. G. Netea, and G. J. Adema. 2006. Toll-like receptor 2 controls expansion and function of regulatory T cells. J. Clin. Investig. 116:485-494.
38. Thompson-Chagoyan, O. C., J. Maldonado, and A. Gil. 2005. Aetiology of inflammatory bowel disease (IBD): role of intestinal microbiota and gut-associated lymphoid tissue immune response. Clin. Nutr. 24:339-352.
39. Ziegler, S. F. 2006. FOXP3: of mice and men. Annu. Rev. Immunol. 24:209-226.